Tech Company Financing Transactions
Isentio Funding Round
Isentio, operating out of Palo Alto, secured $1.5 million from private investors.
Transaction Overview
Company Name
Announced On
5/23/2014
Transaction Type
Venture Equity
Venture Equity
Venture Equity
Amount
$1,500,000
Round
Series A
Investors
Proceeds Purpose
Proceeds will be used for growing its sales and marketing and improving the development team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2600 El Camino Real 601
Palo Alto, CA 94306
USA
Palo Alto, CA 94306
USA
Phone
Website
Email Address
Overview
RipSeq sequence-based analysis reduces the time needed to identify infectious pathogens, in pure- or poly-microbial samples, by up to 90% - and provides answers where other methods fail. Combined with Vivet, RipSeq is a complete SaaS diagnostic solution, able to identify pathogens more accurately, faster and at lower cost than current methods.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Shroff
Chief Marketing Officer
Oyvind Kommedal
Chief Operating Officer
May Roen
Chief Technical Officer
Oystein Saebo
Browse more venture capital transactions:
Prev: 5/23/2014: SunFunder venture capital transaction
Next: 5/23/2014: Vsnap venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs